HIGHLIGHTS OF THIS ISSUE
- Laser procedure relieves angina as a last-resort therapy. // Modern Medicine;May97, Vol. 65 Issue 5, p37
Reports on a study by James Lower on a laser technique known as transmyocardial revascularization (TMR), that can be used a last-resort therapy for angina. Details of the TMR procedure; Effectiveness; Mortality rate; Theories behind the effectiveness of the procedure.
- Laser Revascularization Shows Promise in Recalcitrant Angina. // American Family Physician;4/1/1995, Vol. 51 Issue 5, p1226
Discusses the potential of transmyocardial laser revascularization as a treatment for recalcitrant angina pectoris. Contraindication to coronary angioplasty and bypass surgery among subjects; Identification of fixed and reversible myocardial ischemia; Operative time of laser procedure.
- Abciximab: An Updated Review of its Use in Ischaemic Heart Disease. Foster, R.H.; Wiseman, L.R. // Drugs;Oct1998, Vol. 56 Issue 4, p629
Abciximab is a glycoprotein IIb/IIIa receptor antagonist that has proven to be of significant clinical value in improving patient outcome after percutaneous coronary revascularisation. Primarily, the drug inhibits platelet aggregation, but it may also have anticoagulant activity and other...
- The impact of private-sector provision on equitable utilisation of coronary revascularisation in London. Mindell, J.; Klodawski, E.; Fitzpatrick, J.; Malhotra, N.; McKee, M.; Sanderson, C. // Heart;Aug2008, Vol. 94 Issue 8, p1008
Objective: To investigate the impact of including private- sector data on assessments of equity of coronary revascularisation provision using NHS data only. Design: Analyses of hospital episodes statistics and private-sector data by age, sex and primary care trust (PCT) of residence. For each...
- Minerva. // BMJ: British Medical Journal (International Edition);02/24/2001, Vol. 322 Issue 7284, p500
Offers various medicine-related news briefs, as of February 24, 2001. Correlation between epidural analgesia used during labor and back pain; Rate of coronary angiography and revascularisation in Australia; Revelations regarding the human genome; Others.
- Identifying myocardial revascularization patients at high risk. // Modern Medicine;Apr98, Vol. 66 Issue 4, p42
Presents an abstract of the article `Renal Dysfunction After Myocardial Revascularization: Risk Factors, Adverse Outcomes and Hospital Resource Utilization,' by C.M. Mangano, L.S. Diamondstone, et al from the `Annals of Internal Medicine' dated February 1, 1998.
- MISCELLANEA. // Current Medical Literature: Cardiology;2005, Vol. 24 Issue 4, p93
The article presents the comments of clinicians on several medical studies. These include "Usefulness of exercise-induced changes in plasma levels of brain natriuretic peptide in predicting right ventricular contractile reserve after repair of tetralogy of Fallot," "Cyanotic congenital heart...
- Integrated Coronary Revascularization. Raja, Shahzad G. // Current Medical Literature: Interventional Cardiology Monitor;2006, Vol. 13 Issue 1, p1
Discusses findings of trials which compared percutaneous and surgical coronary revascularization. Concept of hybrid myocardial revascularization or integrated coronary revascularization (ICR); Indications and contraindications of ICR; Technical issues relating to ICR.
- The encouraging 'COURAGE.'. Singh, Sandeep; Bahl, V. K. // Indian Journal of Medical Research;May2008, Vol. 127 Issue 5, p423
The authors comment on the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) which appeared in the 2007 issue of the "New England Journal of Medicine." The study showed that medical therapy of coronary artery disease (CAD) had better results than percutaneous...